Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

PRICED: Capsugel €750m 7NC3 Snr Sec 5.375% at 100

HYC European Market: Deal Flow - General


Issuer

Term

Call

Coupon

Maturity

Size

Ranking

Type

Price

Yield

IPT-PXD

LSF12 Pillar Investments (Capsugel)

7NC3

3y

5.75%

15-May-33

€750m

Snr Sec

Fixed

100

5.75%

-37.5

Priced: 7NC3: 5.75% / 100
Benchmark: DBR 2.3% 15-Feb-33 / Spread +289bp

Final terms: 7NC3 $750m at 5.75%

Price talk: 7NC3: 5.75-6.00%

Upsized from €500m to €650m (min); US$ TLB dropped, total size across EUR TLB and US$ sr sec notes remains EUR1.380bn equuivalent.
IPTs: 7NC2: 6-6.25%

  • Issuer: LSF12 Pillar Investments (US), Inc (Capsugel)
  • Ticker: LSFPIL
  • Business: Leading global manufacturer of hard empty capsules (HEC) with complementary dosage form solutions and health ingredients capabilities. HQ: Basel, Switzerland
  • Corporate Ratings: B1 (Stable) / B+ (Stable) (Moody's/S&P)
  • Issue Ratings: B1/B+ (stable/stable) (Moody's/S&P)
  • Instrument: Senior Secured Notes
  • Size: €750m (up from EUR650m minimum and EUR500m minimum)
  • Format: 144A/Reg S
  • Tenor: 7 year
  • Maturity Date: 15-May-33
  • Coupon: 5.75%
  • Offering Price: 100
  • Yield: 5.75%
  • Spread: +289bp
  • Benchmark: DBR 2.3% 15-Feb-33
  • Call Protection: 7NC3 (50%, Par). MWC at B+50bp. Equity claw: 3y 40% at 105.75. Special call: 10% per year for the first 3 years at 103.
  • Redemption Prices: On or after: 15-May-29: 102.875% and thereafter: 100.000%
  • Interest Payment Dates: Semi-annually in arrears on May 15 and November 15 of each year
  • First Interest Payment Date: 15-Nov-26
  • Trade Date: 30-Apr-26
  • Settlement Date: 15-May-26 (T+10)
  • Identification Numbers:
    • Rule 144A Global Notes
    • ISIN: 336883431
    • Common Code: XS3368834316
    • Regulation S Global Notes
    • ISIN: XS3368834159
    • Common Code: 336883415
  • Use of Proceeds: Along with proceeds from equity contribution, and a EUR830m (up from EUR650m minium and EUR500m minimum) term loan B (US$500m minimum TLB dropped) (total loan and bond deal size approx EUR1.580bn (approx CHF1.38bn equivalent)), to fund the CHF2bn purchase price for the acquisition of a 60% interest in Capsugel by Lone Star from Lonza Group AG (which will retain a 40% minority interest) and provide for cash overfunding to the balance sheet.
  • Joint Global Coordinators and Physical Bookrunners: GS (B&D), Jefferies, BNP, and UBS
  • Joint Bookrunners: BBVA, ING, IMI - Intesa Sanpaolo, RBI, SocGen, UniCredit, and Standard Chartered
  • Listing: The International Stock Exchange (Unregulated)
  • Governing Law: NY Law
  • Denominations: €100k x €1k
  • Equity Sponsor: Lone Star (60%)/Lonza Group AG (40%)
  • Equity Contribution: CHF823m, including Lonza's rollover equity.
  • Roadshow (virtual meetings): Started 27-Apr-26
  • Global Investor Call: 15:00 UKT / 10:00 ET 27-Apr-26
  • Global Call Registration Link: https://www.netroadshow.com/events/login/1PeTHmohVjb76F1RZFBVZuD4N8rNK49hvTb8j
  • Netroadshow Entry Code: Capsgel12026
  • Netroadshow Direct Link: https://www.netroadshow.com/nrs/home/!/?show=bf5c1c4a
  • Global Investor Presentation Public Replay Link: www.netroadshow.com/nrs/home/#!/?show=b2b545b6
  • Books Closed: 15:30 UKT Today. Pricing today UK afternoon
  • Documentation Update: was posted on Netroadshow
  • ToE: 05:40 PM UKT on 30-Apr-26
  • FTT: 08:00 AM UKT on May 1, 2026
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.